|
1
|
Pasparakis M and Vandenabeele P:
Necroptosis and its role in inflammation. Nature. 517:311–320.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vanden Berghe T, Linkermann A,
Jouan-Lanhouet S, Walczak H and Vandenabeele P: Regulated necrosis:
The expanding network of non-apoptotic cell death pathways. Nat Rev
Mol Cell Biol. 15:135–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vandenabeele P, Galluzzi L, Vanden Berghe
T and Kroemer G: Molecular mechanisms of necroptosis: An ordered
cellular explosion. Nat Rev Mol Cell Biol. 11:700–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teng X, Degterev A, Jagtap P, Xing X, Choi
S, Denu R, Yuan J and Cuny GD: Structure-activity relationship
study of novel necroptosis inhibitors. Bioorg Med Chem Lett.
15:5039–5044. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moriwaki K, Bertin J, Gough PJ, Orlowski
GM and Chan FK: Differential roles of RIPK1 and RIPK3 in
TNF-induced necroptosis and chemotherapeutic agent-induced cell
death. Cell Death Dis. 6:e16362015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Almagro MC and Vucic D: Necroptosis:
Pathway diversity and characteristics. Semin Cell Dev Biol.
39:56–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu YZ, Kanagaratham C, Youssef M and
Radzioch D: New Frontiers in Cancer Chemotherapy-Targeting Cell
Death Pathways. In Cell Biology - New Insights. Najman S:
IntechOpen. pp. 93–140. 2016
|
|
8
|
Dondelinger Y, Hulpiau P, Saeys Y,
Bertrand MJM and Vandenabeele P: An evolutionary perspective on the
necroptotic pathway. Trends Cell Biol. 26:721–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Belizário J, Vieira-Cordeiro L and Enns S:
Necroptotic Cell Death Signaling and Execution Pathway: Lessons
from Knockout Mice. Mediators Inflamm. 2015:1280762015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chan FKM, Luz NF and Moriwaki K:
Programmed necrosis in the cross talk of cell death and
inflammation. Annu Rev Immunol. 33:79–106. 2015. View Article : Google Scholar :
|
|
11
|
Avril T, Vauléon E and Chevet E:
Endoplasmic reticulum stress signaling and chemotherapy resistance
in solid cancers. Oncogenesis. 6:e3732017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Palorini R, Votta G, Pirola Y, De Vitto H,
De Palma S, Airoldi C, Vasso M, Ricciardiello F, Lombardi PP,
Cirulli C, et al: Protein Kinase A Activation Promotes Cancer Cell
Resistance to Glucose Starvation and Anoikis. PLoS Genet.
12:e10059312016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Izuishi K, Kato K, Ogura T, Kinoshita T
and Esumi H: Remarkable tolerance of tumor cells to nutrient
deprivation: Possible new biochemical target for cancer therapy.
Cancer Res. 60:6201–6207. 2000.PubMed/NCBI
|
|
14
|
Sato K, Tsuchihara K, Fujii S, Sugiyama M,
Goya T, Atomi Y, Ueno T, Ochiai A and Esumi H: Autophagy is
activated in colorectal cancer cells and contributes to the
tolerance to nutrient deprivation. Cancer Res. 67:9677–9684. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Esumi H, Izuishi K, Kato K, Hashimoto K,
Kurashima Y, Kishimoto A, Ogura T and Ozawa T: Hypoxia and nitric
oxide treatment confer tolerance to glucose starvation in a
5'-AMP-activated protein kinase-dependent manner. J Biol Chem.
277:32791–32798. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SM, Nguyen TT, Ravi A, Kubiniok P,
Finicle BT, Jayashankar V, Malacrida L, Hou J, Robertson J, Gao D,
et al: PTEN deficiency and AMPK activation promote nutrient
scavenging and anabolism in prostate cancer cells. Cancer Discov.
8:866–883. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ranjan A and Iwakuma T: Non-Canonical Cell
Death Induced by p53. Int J Mol Sci. 17:20682016. View Article : Google Scholar
|
|
18
|
Liu X, Chhipa RR, Nakano I and Dasgupta B:
The AMPK inhibitor compound C is a potent AMPK-independent
antiglioma agent. Mol Cancer Ther. 13:596–605. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hardie DG: AMPK and autophagy get
connected. EMBO J. 30:634–635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo Z, Zang M and Guo W: AMPK as a
metabolic tumor suppressor: Control of metabolism and cell growth.
Future Oncol. 6:457–470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mihaylova MM and Shaw RJ: The AMPK
signalling pathway coordinates cell growth, autophagy and
metabolism. Nat Cell Biol. 13:1016–1023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang J and Mills GB: AMPK: A contextual
oncogene or tumor suppressor? Cancer Res. 73:2929–2935. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Faubert B, Boily G, Izreig S, Griss T,
Samborska B, Dong Z, Dupuy F, Chambers C, Fuerth BJ, Viollet B, et
al: AMPK is a negative regulator of the Warburg effect and
suppresses tumor growth in vivo. Cell Metab. 17:113–124. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hardie DG: AMP-activated protein kinase:
An energy sensor that regulates all aspects of cell function. Genes
Dev. 25:1895–1908. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li W, Saud SM, Young MR, Chen G and Hua B:
Targeting AMPK for cancer prevention and treatment. Oncotarget.
6:7365–7378. 2015.PubMed/NCBI
|
|
26
|
Jeon SM, Chandel NS and Hay N: AMPK
regulates NADPH homeostasis to promote tumour cell survival during
energy stress. Nature. 485:661–665. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kato K, Ogura T, Kishimoto A, Minegishi Y,
Nakajima N, Miyazaki M and Esumi H: Critical roles of AMP-activated
protein kinase in constitutive tolerance of cancer cells to
nutrient deprivation and tumor formation. Oncogene. 21:6082–6090.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bunz F, Dutriaux A, Lengauer C, Waldman T,
Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Christofferson DE and Yuan J: Cyclophilin
A release as a biomarker of necrotic cell death. Cell Death Differ.
17:1942–1943. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin Y, Choksi S, Shen H-M, Yang Q-F, Hur
GM, Kim YS, Tran JH, Nedospasov SA and Liu ZG: Tumor necrosis
factor-induced nonapoptotic cell death requires
receptor-interacting protein-mediated cellular reactive oxygen
species accumulation. J Biol Chem. 279:10822–10828. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dashzeveg N and Yoshida K: Cell death
decision by p53 via control of the mitochondrial membrane. Cancer
Lett. 367:108–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vaseva AV, Marchenko ND, Ji K, Tsirka SE,
Holzmann S and Moll UM: p53 opens the mitochondrial permeability
transition pore to trigger necrosis. Cell. 149:1536–1548. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Montero J, Dutta C, van Bodegom D,
Weinstock D and Letai A: p53 regulates a non-apoptotic death
induced by ROS. Cell Death Differ. 20:1465–1474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsujimoto Y and Shimizu S: Role of the
mitochondrial membrane permeability transition in cell death.
Apoptosis. 12:835–840. 2007. View Article : Google Scholar
|
|
35
|
Eguchi Y, Shimizu S and Tsujimoto Y:
Intracellular ATP levels determine cell death fate by apoptosis or
necrosis. Cancer Res. 57:1835–1840. 1997.PubMed/NCBI
|
|
36
|
Tatsumi T, Shiraishi J, Keira N, Akashi K,
Mano A, Yamanaka S, Matoba S, Fushiki S, Fliss H and Nakagawa M:
Intracellular ATP is required for mitochondrial apoptotic pathways
in isolated hypoxic rat cardiac myocytes. Cardiovasc Res.
59:428–440. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liou G-Y and Storz P: Reactive oxygen
species in cancer. Free Radic Res. 44:479–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Redza-Dutordoir M and Averill-Bates DA:
Activation of apoptosis signalling pathways by reactive oxygen
species. Biochim Biophys Acta. 1863:2977–2992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Marchi S, Giorgi C, Suski JM, Agnoletto C,
Bononi A, Bonora M, De Marchi E, Missiroli S, Patergnani S, Poletti
F, et al: Mitochondriaros crosstalk in the control of cell death
and aging. J Signal Transduct. 2012:3296352012. View Article : Google Scholar
|
|
40
|
Fulda S: The mechanism of necroptosis in
normal and cancer cells. Cancer Biol Ther. 14:999–1004. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kaczmarek A, Vandenabeele P and Krysko DV:
Necroptosis: The release of damage-associated molecular patterns
and its physiological relevance. Immunity. 38:209–223. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dasgupta A, Nomura M, Shuck R and Yustein
J: Cancer's Achilles' Heel: Apoptosis and Necroptosis to the
Rescue. Int J Mol Sci. 18:232016. View Article : Google Scholar
|
|
43
|
González-Juarbe N, Gilley RP, Hinojosa CA,
Bradley KM, Kamei A, Gao G, Dube PH, Bergman MA and Orihuela CJ:
Pore-Forming Toxins Induce Macrophage Necroptosis during Acute
Bacterial Pneumonia. PLoS Pathog. 11:e10053372015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Steinberg GR and Kemp BE: AMPK in Health
and Disease. Physiol Rev. 89:1025–1078. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Oakhill JS, Chen Z-P, Scott JW, Steel R,
Castelli LA, Ling N, Macaulay SL and Kemp BE: β-Subunit
myristoylation is the gatekeeper for initiating metabolic stress
sensing by AMP-activated protein kinase (AMPK). Proc Natl Acad Sci
USA. 107:19237–19241. 2010. View Article : Google Scholar
|
|
46
|
Yung MMH, Ngan HYS and Chan DW: Targeting
AMPK signaling in combating ovarian cancers: Opportunities and
challenges. Acta Biochim Biophys Sin (Shanghai). 48:301–317. 2016.
View Article : Google Scholar
|
|
47
|
Wang W, Yang X, López de Silanes I,
Carling D and Gorospe M: Increased AMP:ATP ratio and AMP-activated
protein kinase activity during cellular senescence linked to
reduced HuR function. J Biol Chem. 278:27016–27023. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Grahame Hardie D: Regulation of
AMP-activated protein kinase by natural and synthetic activators.
Acta Pharm Sin B. 6:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Smith AC, Bruce CR and Dyck DJ: AMP kinase
activation with AICAR simultaneously increases fatty acid and
glucose oxidation in resting rat soleus muscle. J Physiol.
565:537–546. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tu HC, Ren D, Wang GX, Chen DY, Westergard
TD, Kim H, Sasagawa S, Hsieh JJD and Cheng EHY: The p53-cathepsin
axis cooperates with ROS to activate programmed necrotic death upon
DNA damage. Proc Natl Acad Sci USA. 106:1093–1098. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Koo MJ, Rooney KT, Choi ME, Ryter SW, Choi
AMK and Moon JS: Impaired oxidative phosphorylation regulates
necroptosis in human lung epithelial cells. Biochem Biophys Res
Commun. 464:875–880. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Meisse D, Van de Casteele M, Beauloye C,
Hainault I, Kefas BA, Rider MH, Foufelle F and Hue L: Sustained
activation of AMP-activated protein kinase induces c-Jun N-terminal
kinase activation and apoptosis in liver cells. FEBS Lett.
526:38–42. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Okoshi R, Ozaki T, Yamamoto H, Ando K,
Koida N, Ono S, Koda T, Kamijo T, Nakagawara A and Kizaki H:
Activation of AMP-activated protein kinase induces p53-dependent
apoptotic cell death in response to energetic stress. J Biol Chem.
283:3979–3987. 2008. View Article : Google Scholar
|
|
54
|
Ferretti AC, Tonucci FM, Hidalgo F, Almada
E, Larocca MC and Favre C: AMPK and PKA interaction in the
regulation of survival of liver cancer cells subjected to glucose
starvation. Oncotarget. 7:17815–17828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Huang SW, Wu CY, Wang YT, Kao JK, Lin CC,
Chang CC, Mu SW, Chen YY, Chiu HW, Chang CH, et al: p53 modulates
the AMPK inhibitor compound C induced apoptosis in human skin
cancer cells. Toxicol Appl Pharmacol. 267:113–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lee CW, Wong LL, Tse EY, Liu HF, Leong VY,
Lee JM, Hardie DG, Ng IO and Ching YP: AMPK promotes p53
acetylation via phosphorylation and inactivation of SIRT1 in liver
cancer cells. Cancer Res. 72:4394–404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Maiuri MC, Galluzzi L, Morselli E, Kepp O,
Malik SA and Kroemer G: Autophagy regulation by p53. Curr Opin Cell
Biol. 22:181–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Scherz-Shouval R, Weidberg H, Gonen C,
Wilder S, Elazar Z and Oren M: p53-dependent regulation of
autophagy protein LC3 supports cancer cell survival under prolonged
starvation. Proc Natl Acad Sci USA. 107:18511–18516. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Tasdemir E, Chiara Maiuri M, Morselli E,
Criollo A, D'Amelio M, Djavaheri-Mergny M, Cecconi F, Tavernarakis
N and Kroemer G: A dual role of p53 in the control of autophagy.
Autophagy. 4:810–814. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Fitzwalter BE and Thorburn A: Recent
insights into cell death and autophagy. FEBS J. 282:4279–4288.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Boya P, González-Polo R-A, Casares N,
Perfettini J-L, Dessen P, Larochette N, Métivier D, Meley D,
Souquere S, Yoshimori T, et al: Inhibition of macroautophagy
triggers apoptosis. Mol Cell Biol. 25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Nikoletopoulou V, Markaki M, Palikaras K
and Tavernarakis N: Crosstalk between apoptosis, necrosis and
autophagy. Biochim Biophys Acta. 1833:3448–3459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Nugues AL, El Bouazzati H, Hétuin D,
Berthon C, Loyens A, Bertrand E, Jouy N, Idziorek T and Quesnel B:
RIP3 is down-regulated in human myeloid leukemia cells and
modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell
Death Dis. 5:e13842014. View Article : Google Scholar
|
|
64
|
Koo G-B, Morgan MJ, Lee D-G, Kim W-J, Yoon
J-H, Koo JS, Kim SI, Kim SJ, Son MK, Hong SS, et al:
Methylation-dependent loss of RIP3 expression in cancer represses
programmed necrosis in response to chemotherapeutics. Cell Res.
25:707–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yang C, Li J, Yu L, Zhang Z, Xu F, Jiang
L, Zhou X and He S: Regulation of RIP3 by the transcription factor
Sp1 and the epigenetic regulator UHRF1 modulates cancer cell
necroptosis. Cell Death Dis. 8:e30842017. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Su Z, Yang Z, Xie L, DeWitt JP and Chen Y:
Cancer therapy in the necroptosis era. Cell Death Differ.
23:748–756. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang Z, Jiang H, Chen S, Du F and Wang X:
The mitochondrial phosphatase PGAM5 functions at the convergence
point of multiple necrotic death pathways. Cell. 148:228–243. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Brown MF, Leibowitz BJ, Chen D, He K, Zou
F, Sobol RW, Beer-Stolz D, Zhang L and Yu J: Loss of caspase-3
sensitizes colon cancer cells to genotoxic stress via
RIP1-dependent necrosis. Cell Death Dis. 6:e17292015. View Article : Google Scholar : PubMed/NCBI
|
